Actively Recruiting

Phase Not Applicable
Age: 14Years - 25Years
All Genders
NCT05968560

Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis

Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-01-20

72

Participants Needed

1

Research Sites

179 weeks

Total Duration

On this page

Sponsors

I

Icahn School of Medicine at Mount Sinai

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Psychosis typically emerges during late adolescence or early adulthood, significantly impacting long-term functioning. While CHR programs have the potential to reduce illness severity, individuals often face barriers such as stigma and limited access to services. Telehealth interventions could address these barriers and improve treatment accessibility and engagement. The study will focus on Group and Family-Based Cognitive Behavioral Therapy, Family-Based CBT, and individual CBT, adapted for telehealth delivery (GF-CBT-TH, F-CBT-TH, and I-CBT-TH). Participants aged 14-25 who meet CHR criteria will be randomly assigned to one of these interventions. Feasibility will be measured by recruitment rate, attendance, and retention. The study will assess the impact of the interventions on cognitive biases, social connectedness, family emotional climate, and proficiency in CBT skills. The three intervention groups will be compared in terms of psychosocial functioning, symptom severity, rates of remission from CHR, and rates of transition to psychosis. Additionally, factors like patient treatment preference, family emotional climate, and sociodemographic factors will be explored as potential moderators of treatment outcomes. Qualitative interviews will be conducted with participants and clinicians to inform dissemination efforts.

CONDITIONS

Official Title

Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis

Who Can Participate

Age: 14Years - 25Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 14-25
  • Ability to participate in assessments and treatment in English
  • Meets criteria for psychosis-risk on SIPS
  • Stable on medications with no changes within 1 month prior to enrollment
  • Has a family member, blood relative, spouse, significant other, or close friend with more than 4 hours per week contact willing to participate
Not Eligible

You will not qualify if you...

  • Intellectual disability with IQ less than 70
  • Medical conditions known to cause psychosis
  • Moderate or severe substance use disorder with active use within the past 30 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

Loading map...

Research Team

Y

Yulia Landa, PsyD, MS

CONTACT

R

Rachel Jespersen, LMSW

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here